NaV1.7 inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/03/20 15:59:00
NME

Base Information

Drug NameNaV1.7 inhibitors (Bristol-Myers Squibb)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type IX alpha subunit blockers
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A